Viewing Study NCT06250582



Ignite Creation Date: 2024-05-06 @ 8:06 PM
Last Modification Date: 2024-10-26 @ 3:20 PM
Study NCT ID: NCT06250582
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-03-15
First Post: 2023-12-20

Brief Title: Does Virtual Reality Improve Symptom Burden in Dialysis Patients
Sponsor: David Blum
Organization: University of Zurich

Study Overview

Official Title: Does Virtual Reality Improve Symptom Burden in Dialysis Patients
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to investigate the use of virtual reality therapy in dialysis patients The main question it aims to answer is Does virtual reality improve symptom burden in dialysis patients and improve their mental wellbeing Over a period of one month one virtual reality therapy session of 30 minutes will be performed during each regular hemodialysis session Since we will conduct a monocentric crossover randomized controlled trial the participants act as their own control group
Detailed Description: Hemodialysis is a lifesaving therapy for patients with end stage kidney disease but comes with a high burden of physical and emotional symptoms that lower quality of life in dialysis patients Dialysis mediated complications such as drops in blood pressure nausea and muscle cramps results in refusal and a negative perception of this treatment In dialysis patients treatment-related burden results in deterioration in health related quality of life During the past few years Virtual reality VR has become more affordable and found its way into households as entertainment electronics but stepwise also into medicine VR enables the user to view interact and be immersed in a multisensory 3D virtual world The aim of the current study is to reduce dialysis-related burden of symptoms by using virtual reality therapy during regular dialysis sessions and thereby improve quality of life among dialysis patients

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None